A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
about
The Role of Imaging in Aortic Valve DiseaseT1 mapping in cardiac MRI.Effects of Aortic Valve Replacement on Severe Aortic Stenosis and Preserved Systolic Function: Systematic Review and Network Meta-analysisFree-of-Acrylamide SDS-based Tissue Clearing (FASTClear) for three dimensional visualization of myocardial tissue.New considerations in the assessment of aortic stenosis.Biomarkers of Calcific Aortic Valve Disease.Multimodality imaging for the diagnosis and assessment of aortic stenosis severity.Severe and Asymptomatic Aortic Stenosis Management Challenge: Knowing That We Do Not Really Know.High-Sensitive Cardiac Troponin T as an Early Biochemical Signature for Clinical and Subclinical Heart Failure: MESA (Multi-Ethnic Study of Atherosclerosis).Cardiac myosin-binding protein C is a novel marker of myocardial injury and fibrosis in aortic stenosis.The assessment of aortic stenosis: looking beyond the valve.Ethical Issues--the challenge to keep up with a changing environment.Imaging and outcomes in cardiac, valvular, and peripheral arterial disease.Nrf2 Is a Key Regulator on Puerarin Preventing Cardiac Fibrosis and Upregulating Metabolic Enzymes UGT1A1 in Rats.Defining myocardial fibrosis in haemodialysis patients with non-contrast cardiac magnetic resonancePredicting Disease Progression and Mortality in Aortic Stenosis: A Systematic Review of Imaging Biomarkers and Meta-Analysis
P2860
Q26744817-B03838D6-2D85-4B5F-B567-F2B5968EF8CAQ33844044-CFA318C1-3B63-446A-9061-7301D1B9F73EQ33894813-7CC496CC-8496-4242-B235-B7B3EE9E0D1BQ33899212-56D2F512-40FC-448F-A442-56B8D098DE89Q38638916-BEE3E727-A8EE-41D7-8392-22F1822EED00Q38762609-45031021-E4D0-4DC8-AC7F-570563FCB73CQ38899696-2E55B776-66F8-48AC-AC12-17A41A6F62F8Q39212445-BFD096F6-FCB0-4CB5-AAE9-D891600D4D94Q40350551-C46BE0A1-9BC4-45CA-A749-335914EA35DBQ47340269-C51BF53F-729D-4F44-894A-1F98B8340A3AQ47579885-0B61E285-4321-42C0-A908-B1FB08C939EDQ47809547-9884A8D3-B885-4414-AA77-45E983AFC3DCQ52984783-B7AFE19F-0436-45DE-9870-206CF5666E5DQ55286731-9CBF37F4-6D3B-49A9-BAB6-DCED6C652F1FQ57823261-B6C2FAA1-88A3-4749-BB7F-C8DF91C626DEQ58719773-B6ABBBAF-3F5E-410C-9850-1C1B6FDF03EC
P2860
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@ast
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@en
type
label
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@ast
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@en
prefLabel
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@ast
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@en
P2093
P2860
P50
P356
P1476
A clinical risk score of myocardial fibrosis predicts adverse outcomes in aortic stenosis
@en
P2093
Alec Vahanian
Anoop S V Shah
David E Newby
David Messika-Zeitoun
Emily N W Yeung
Guillaume Lefevre
Saeed Mirsadraee
Scott I Semple
Sophie Bailleul
P2860
P304
P356
10.1093/EURHEARTJ/EHV525
P577
2015-10-21T00:00:00Z